Updates in Prevalence, Risk Factors, Management and Outcome of Treatment of Acute Pancreatitis

Khalil Salameh Yakoub Al Neimat; Abdulmalek Khaled Alserhany; Munif Eid Alanazi; Abdulaziz Alhumaidi Alanazi; Naif Eid Alanazi; Majed Ahmed Alanazi; Faisal Abdulaziz Almulhim; Ibrahim Ahmed Alazmi; Abdulmajeed Qasem Alanazi; Abdulrahman Saud Alsharari; Meshal Mohammed Alsharari; Daham Abdullah Aldaham; Noor Hassan Alazmi

doi:10.51847/TYrK6XBCYe

Open Access | Published: 2022 - Issue 4

Updates in Prevalence, Risk Factors, Management and Outcome of Treatment of Acute Pancreatitis Download PDF

Khalil Salameh Yakoub Al Neimat , Abdulmalek Khaled Alserhany , Munif Eid Alanazi , Abdulaziz Alhumaidi Alanazi , Naif Eid Alanazi , Majed Ahmed Alanazi , Faisal Abdulaziz Almulhim , Ibrahim Ahmed Alazmi , Abdulmajeed Qasem Alanazi , Abdulrahman Saud Alsharari , Meshal Mohammed Alsharari , Daham Abdullah Aldaham , Noor Hassan Alazmi

Abstract

A frequent pancreatic condition is acute pancreatitis. It is unique of the main reasons of in hospice fatalities along with the greatest mutual gastrointestinal reason for admission. As of a moderate, self-limiting condition to a stark case of acute necrotizing pancreatitis marked by general consequences and multi organ failure, it can fluctuate in severity. Acute pancreatitis is often identified in a hospital setting, wherever the case will also get care and be kept under close observation for problems. Uncertainty the case has serious pancreatitis, the physician might inquire about his indicators and may even examine his abdomen, which will be quite sensitive.

Early intensive fluid therapy remains the basis for the management of acute pancreatitis. In the absence of additional contraindications, a bolus of 15-20 mL / kg lactated Ringer solution is recommended. Then, for the first 24 hours, administer at a rate of 3 mL/kg per hour (often 250-500 mL per hour). Monitor fluid resuscitation using a combination of blood urea nitrogen, hematocrit, and urine volume to change fluid volume during the first 24 hours of resuscitation.

Cite this article

Vancouver

Al Neimat KSY, Alserhany AK, Alanazi ME, Alanazi AA, Alanazi NE, Alanazi MA, et al. Updates in Prevalence, Risk Factors, Management and Outcome of Treatment of Acute Pancreatitis. Pharmacophore. 2022;13(4):1-7. https://doi.org/10.51847/TYrK6XBCYe

APA

Al Neimat, K. S. Y., Alserhany, A. K., Alanazi, M. E., Alanazi, A. A., Alanazi, N. E., Alanazi, M. A., Almulhim, F. A., Alazmi, I. A., Alanazi, A. Q., Alsharari, A. S., et al. (2022). Updates in Prevalence, Risk Factors, Management and Outcome of Treatment of Acute Pancreatitis. Pharmacophore, 13(4), 1-7. https://doi.org/10.51847/TYrK6XBCYe

EndNote RIS

Full HTML

QR code:

Short Link:

https://pharmacophorejournal.com/TYrK6XBCYe

Downloads: 255

Quick Access

Author Guidelines

Manuscript Submission

Joining Editorial Board

Joining Reviewers Team

Associations